DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

DRG Oncology

Innovate | Differentiate  |  Demonstrate

DRG Oncology is an alliance of world-renowned healthcare experts and thought leaders working together to deliver trusted insights and market perspectives that drive your complex clinical and commercial decisions in oncology.


Leverage our oncology expertise.

  • Your partner in advancing cancer care for 20+ years
  • 130+ Life sciences companies used DRG Oncology research and services in 2016
  • 80% of the top 30 global oncology companies rely on our oncology insights for business strategy


Our expert, cross-functional team of analysts, epidemiologists, data scientists, and consultants know your markets and understand your needs. They also understand how to transform data analysis into meaningful insights and solutions that empower our partners to answer pressing challenges critical to their success.

Meet our experts, just click here.


DRG Oncology expert insights give you the edge.

DRG’s market assessment insight continues to be the leading business intelligence and decision support resource for life science organizations after more than two decades.

The DRG Oncology team continues this heritage and analyzes drugs, sales, prescribing patterns, etc. to provide you with critical insights by disease, company, and drug. Oncology indication market insights are delivered through 6 modules, each providing a different perspective and analysis on the oncology market.

See our full Market Assessment Product Suite

Request A Demo